Population,Intervention,Comparison,Outcome,Measure,Effect,CI Lower,CI Upper,Significant,Number of participants,Number of studies,Certainty of the evidence (GRADE),Reasons for GRADE if not High,Risk of bias,Imprecision,Inconsistency,Indirectness,Publication bias
people with haemophilia or Von Willebrand disease,tranexamic acid (TXA) or epsilon aminocaproic acid (EACA),placebo or no intervention or usual care with or without placebo,Postoperative bleedings requiring intervention,RD,57,36,76,TRUE,59,2,MODERATE,"The magnitude of effect was considered large in this study, therefore the quality of evidence was rated up one level.
Small sample sizes and lack of studies
Heterogeneity between the included trials regarding the proportion of severe people with haemophilia included, the concomitant standard therapy and fibrinolytic agent treatment regimens used",FALSE,TRUE,TRUE,FALSE,FALSE
people with haemophilia or Von Willebrand disease,tranexamic acid (TXA) or epsilon aminocaproic acid (EACA),placebo or no intervention or usual care with or without placebo,Side effects or other adverse events,RD,3.4,-32,38,FALSE,59,2,LOW,"Small sample sizes and lack of studies
Heterogeneity between the included trials regarding the proportion of severe people with haemophilia included, the concomitant standard therapy and fibrinolytic agent treatment regimens used",FALSE,TRUE,TRUE,FALSE,FALSE
